I have been very fortunate – its been nearly three years since my diagnosis and I am NED (no evidence of disease, or the solid tumor equivalent of remission which is more commonly used for liquid […]
CYP2D6*4 polymorphism: A new marker of response to hormonotherapy in male breast cancer? Abreu MH, Gomes M, Menezes F, Afonso N, Abreu PH, Medeiros R, Pereira D, Lopes C. Breast. 2015 Aug;24(4):481-6. doi: 10.1016/j.breast.2015.04.010. Epub […]
Aromatase inhibitors in male breast cancer: a pooled analysis Zagouri F, Sergentanis TN, Azim HA Jr, Chrysikos D, Dimopoulos MA, Psaltopoulou T Breast Cancer Res Treat. 2015 May;151(1):141-7. doi: 10.1007/s10549-015-3356-9. Epub 2015 Apr 8. Background […]
I am very excited about this new prospective study of male breast cancer that was just announced. As the press release (below) states: “The second part of this Program, which is now open, is a […]
Earlier this week I blogged about the cancer conference, the WIN Symposium which I attended last week. I summarized some of the current challenges in developing personalized cancer therapies, including the complexity of cancer. The […]
In another month or so, I am joining an immunotherapy clinical trial that is aimed at suppressing recurrence, by training the immune system to pay attention to cancer cells more effectively. It is a trial designed […]
In a recent post I discussed the underfunding of basic research on the male form of breast cancer, and advocated for 1% of breast cancer research funding to involve male disease, in proportion to 1% […]
A new study of the impact of long-term hormone treatment using Tamoxifen, which was presented this week as the San Antonio Breast Cancer Symposium (www.sabcs.org), showed that 10 years was significantly better at suppressing recurrence and promoti…
On day 38 I wrote about side effects and how they tell you things are working. Well, there are some that overshoot that mark a little, and can cause real harm. While no side effects are great, many are temporary and can be managed, such as hair lo…
You read a lot about personalized cancer therapy both in scientific journals and in the general press. The idea is that in the (near) future doctors will be able to learn a lot more information about your tumor, and pick just the right therapy to …
